|Articles|May 5, 2023
Pharma 2023: Working with Patient Advocacy Groups
Rebecca Vermeulen, VP Global Patient Networks, Product Development Medical Affairs for Roche discusses how they approach patient engagement.
Advertisement
Rebecca Vermeulen, VP Global Patient Networks, Product Development Medical Affairs for Roche discusses how the role of patient advocacy groups to improve patient engagement, how Roche organizes their relationships and the key takeaways for industry professionals.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection
2
Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals
3
When Ambition Meets Ambiguity: The Trends and Sentiments Shaping Biotech in 2026
4
JCA vs. Reality: Europe’s Push for Clinical Harmonization
5